Black Diamond Therapeutics (BDTX) R&D/CAPEX US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 103 586% | 33 950% | 3 573% | 33 561% | 178 524% | 87 833% | |||
Changes by years, y/y, % | +94 441pp | -69 636pp | -30 377pp | +29 988pp | +144 963pp | +81.2% |
Black Diamond Therapeutics. R&D/CAPEX, %
Black Diamond Therapeutics. R&D/CAPEX, changes, pp
Black Diamond Therapeutics (BDTX) R&D/CAPEX US GAAP (quarter values) |
||||||||
2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
R&D/CAPEX, % | 7 305% | 48 952% | 46 070% | 87 833% | ||||
Changes by years, y/y, % | -15 839pp | -254 086pp | -8 391pp | -149 136pp | +38 765pp | |||
Changes by quarters, q/q, % | -190 783pp | -7 305pp | -2 882pp |